[go: up one dir, main page]

WO2002006534A3 - Diagnostic de l'hypertension artérielle pulmonaire - Google Patents

Diagnostic de l'hypertension artérielle pulmonaire Download PDF

Info

Publication number
WO2002006534A3
WO2002006534A3 PCT/US2001/022492 US0122492W WO0206534A3 WO 2002006534 A3 WO2002006534 A3 WO 2002006534A3 US 0122492 W US0122492 W US 0122492W WO 0206534 A3 WO0206534 A3 WO 0206534A3
Authority
WO
WIPO (PCT)
Prior art keywords
pulmonary hypertension
diagnosing
individual
diagnosing pulmonary
fpph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/022492
Other languages
English (en)
Other versions
WO2002006534A2 (fr
Inventor
James E Loyd
Kirk B Lane
John A Phillips Iii
William C Nichols
Michael W Pauciulo
Tatiana Foroud
Richard C Trembath
Rajiv D Machado
Jennifer R Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Cincinnati Childrens Hospital Medical Center
Indiana University Research and Technology Corp
Vanderbilt University
Original Assignee
University of Leicester
Cincinnati Childrens Hospital Medical Center
Indiana University Research and Technology Corp
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester, Cincinnati Childrens Hospital Medical Center, Indiana University Research and Technology Corp, Vanderbilt University filed Critical University of Leicester
Priority to AU2001276957A priority Critical patent/AU2001276957A1/en
Publication of WO2002006534A2 publication Critical patent/WO2002006534A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002006534A3 publication Critical patent/WO2002006534A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne d'une façon générale un procédé permettant, d'une part d'identifier un sujet susceptible plus que d'autres de développer l'hypertension artérielle pulmonaire primaire familiale, et d'autre part de diagnostiquer un sujet souffrant de cette affection. L'invention concerne également un procédé permettant, non seulement d'identifier un sujet susceptible plus que d'autres de développer l'hypertension artérielle pulmonaire primaire (non familiale), mais aussi de diagnostiquer un sujet souffrant de cette affection.
PCT/US2001/022492 2000-07-17 2001-07-17 Diagnostic de l'hypertension artérielle pulmonaire Ceased WO2002006534A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001276957A AU2001276957A1 (en) 2000-07-17 2001-07-17 Method of diagnosing pulmonary hypertension

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21874000P 2000-07-17 2000-07-17
US60/218,740 2000-07-17
US22013300P 2000-07-21 2000-07-21
US60/220,133 2000-07-21

Publications (2)

Publication Number Publication Date
WO2002006534A2 WO2002006534A2 (fr) 2002-01-24
WO2002006534A3 true WO2002006534A3 (fr) 2003-02-13

Family

ID=26913204

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022492 Ceased WO2002006534A2 (fr) 2000-07-17 2001-07-17 Diagnostic de l'hypertension artérielle pulmonaire

Country Status (3)

Country Link
US (2) US6642002B2 (fr)
AU (1) AU2001276957A1 (fr)
WO (1) WO2002006534A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20070105121A1 (en) * 1999-01-06 2007-05-10 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20060134635A1 (en) * 2001-02-28 2006-06-22 Chondrogene Limited Method for the detection of coronary artery disease related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US6800440B2 (en) * 2000-07-12 2004-10-05 The Trustees Of Columbia University In The City Of New York Role of PPH1 gene in pulmonary hypertension
WO2004058293A1 (fr) * 2002-12-24 2004-07-15 Northern Therapeutics Inc. Procedes de diagnostic, de prevention et de traitement de l'apparition precoce de l'hypertension pulmonaire
AU2005294265A1 (en) * 2004-10-06 2006-04-20 University Of Rochester Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
TWM288873U (en) * 2005-09-29 2006-03-21 Shih-Hsien Huang Connection device for car windshield wiper arm
US7299520B2 (en) * 2006-03-24 2007-11-27 Shih-Hsien Huang Connecting device for a windshield wiper having no support frame and hook type windshield wiper arm
US20070221365A1 (en) * 2006-03-24 2007-09-27 Evapco, Inc. U-shaped heat exchanger tube with a concavity formed into its return bend
CN114107482A (zh) * 2021-11-29 2022-03-01 百世诺(北京)医学检验实验室有限公司 肺动脉高压突变基因及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004684A1 (fr) * 2000-07-12 2002-01-17 The Trustees Of Columbia University In The City Of New York Role du gene pph1 dans l'hypertension arterielle pulmonaire
WO2002016398A2 (fr) * 2000-08-25 2002-02-28 Genaissance Pharmaceuticals, Inc. Haplotypes du gene bmpr2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601438A (fr) 1968-10-17 1970-08-24
US6291054B1 (en) * 1999-02-19 2001-09-18 E. I. Du Pont De Nemours And Company Abrasion resistant coatings

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004684A1 (fr) * 2000-07-12 2002-01-17 The Trustees Of Columbia University In The City Of New York Role du gene pph1 dans l'hypertension arterielle pulmonaire
WO2002016398A2 (fr) * 2000-08-25 2002-02-28 Genaissance Pharmaceuticals, Inc. Haplotypes du gene bmpr2

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 5 October 1995 (1995-10-05), ROSENZWEIG ET AL.: "H. sapiens mRNA for BMPR-II" *
DENG Z ET AL: "FAMILIAL PRIMARY PULMONARY HYPERTENSION (GENE PPH1) IS CAUSED BY MUTATIONS IN THE BONE MORPHOGENETIC PROTEIN RECEPTOR-II GENE", AMERICAN JOURNAL OF HUMAN GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL, US, no. 67, 2000, pages 737 - 744, XP002909518, ISSN: 0002-9297 *
LANE K B ET AL: "HETEROZYGOUS GERMLINE MUTATIONS IN BMPR2, ENCODING A TGF-BETA RECEPTOR, CAUSE FAMILIAL PRIMARY PULMONARY HYPERTENSION", NATURE GENETICS, NATURE AMERICA, NEW YORK, US, vol. 26, September 2000 (2000-09-01), pages 81 - 84, XP002907136, ISSN: 1061-4036 *
MACHADO R D ET AL: "BMPR2 HAPLOINSUFFICIENCY AS THE INHERITED MOLECULAR MECHANISM FOR PRIMARY PULMONARY HYPERTENSION", AMERICAN JOURNAL OF HUMAN GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL, US, no. 68, 2001, pages 92 - 102, XP002909517, ISSN: 0002-9297 *
ROSENZWEIG B L ET AL: "CLONING AND CHARACTERIZATION OF A HUMAN TYPE II RECEPTOR FOR BONE MORPHOGENETIC PROTEINS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, Z48923, 1 August 1995 (1995-08-01), pages 7632 - 7636, XP002021530, ISSN: 0027-8424, Retrieved from the Internet <URL:HTTP://WWW.EBI.UK.AC> *
THOMSON JENNIFER R ET AL: "Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.", JOURNAL OF MEDICAL GENETICS, vol. 37, no. 10, October 2000 (2000-10-01), pages 741 - 745, XP001118640, ISSN: 0022-2593 *

Also Published As

Publication number Publication date
US6642002B2 (en) 2003-11-04
US20040023280A1 (en) 2004-02-05
WO2002006534A2 (fr) 2002-01-24
AU2001276957A1 (en) 2002-01-30
US20020102576A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
WO2002006534A3 (fr) Diagnostic de l&#39;hypertension artérielle pulmonaire
WO2003071927A3 (fr) Methodes permettant de diagnostiquer et de traiter des troubles lies a la degenerescence maculaire
EP1414343A4 (fr) Systemes bases sur l&#39;electroencephalographie et methodes de selection de therapies et de prediction de resultats
WO2000018899A3 (fr) Homologue d&#39;enzyme de conversion d&#39;angiotensine et son utilisation
WO2001084149A3 (fr) Diagnostic et therapeutique pour des troubles lies a une degenerescence maculaire
WO2005017646A3 (fr) Système, logiciel et procédés pour l&#39;identification de biomarqueurs
WO2001096877A3 (fr) Nouveaux cryptates de metal des terres rares peu sensibles a l&#39;extinction de fluorescence
ATE271037T1 (de) Substituierte karbazole, verfahren zu ihrer herstellung und ihre verwendung als spla2- inhibitoren
AU2002246702A1 (en) Method of screening for gpr40 ligands
WO2003038444A3 (fr) Biomarqueurs de reponse hepatique
EP1080227A4 (fr) Nouveau procede de diagnostic, de surveillance et de stadification du cancer du colon
WO1999025843A3 (fr) Kinase humaine de controle, hcds1, compositions et procedes
WO2003004681A3 (fr) Molecules d&#39;acides nucleiques codant une serine protease 20 transmembranaire, les polypeptides codes et les methodes correspondantes
WO2005026392A3 (fr) Compositions, reactifs, et kits et procede de diagnostic, de controle et de traitement de l&#39;obesite et/ou du diabete
WO2002012471A3 (fr) Homologue de l&#39;enzyme de conversion de l&#39;angiotensine et utilisations
WO2000014206A3 (fr) Cellulase mutante egiii, adn codant ces compositions d&#39;egiii et leurs procedes de preparation
WO2002004678A3 (fr) Diagnostic et traitement de la pré-éclampsie et des troubles trophoblastiques de la gestation et compositions à cet effet
WO2005035719A3 (fr) Luciferase modifiee
WO2004048930A3 (fr) METHODE PERMETTANT DE CONTRER UN CHANGEMENT PATHOLOGIQUE DANS LA VOIE ss-ADRENERGIQUE
WO2004070950A3 (fr) Dispositif de codage d&#39;un flot de donnees video
WO2004098391A3 (fr) Methodes de detection d&#39;infections a parvovirus
WO2003028005A3 (fr) Procede de caracterisation du timbre d&#39;un signal sonore selon au moins un descripteur
WO2003014386A3 (fr) Procede d&#39;identification de polyketides macrocycliques
EP1104814A3 (fr) Procédé pour la prédiction du risque de développer un emphysème pulmonaire chronique
WO2002006487A3 (fr) Sequences de regulation a partir de cellules meristematiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP